Circulating tumor cell composition in renal cell carcinoma

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Nel, Ivonne ^a,b   Gauler, Thomas C ^a,c   Bublitz, Kira ^a   Lazaridis, Lazaros ^a   Goergens, André ^a   Giebel, Bernd ^a   Schuler, Martin ^a,c   Hoffmann, Andreas Claudius ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b BMZ2 ^*  (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; FIBROBLAST GROWTH FACTOR RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NERVE CELL ADHESION MOLECULE; TUMOR MARKER; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER PROGNOSIS; CELL COMPOSITION; CIRCULATING TUMOR CELL; CONTROLLED STUDY; EPITHELIUM CELL; FGFR GENE; GENE EXPRESSION; HIF1A GENE; HUMAN; HUMAN CELL; KIDNEY METASTASIS; MESENCHYMAL STEM CELL; PILOT STUDY; PROGRESSION FREE SURVIVAL; VEGFA GENE; VEGFR GENE; BLOOD; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; HEP-G2 CELL LINE; KIDNEY CARCINOMA; KIDNEY TUMOR; MIDDLE AGED; TUMOR EMBOLISM;

ADULT; AGED; CARCINOMA, RENAL CELL; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; HEP G2 CELLS; HUMANS; KIDNEY NEOPLASMS; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING;

EID: 84964679060     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153018     Document Type: Article

References (45)

1. Lianidou ES, Markou A, (2011) Circulating tumor cells as emerging tumor biomarkers in breast cancer. Clin Chem Lab Med 49:1579-1590. doi: 10.1515/CCLM.2011.628 PMID: 21801030
2. O'Flaherty JD, Gray S, Richard D, Fennell D, O'Leary JJ, Blackhall FH, et al. (2012) Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. Lung Cancer 76:19-25. doi: 10. 1016/j.lungcan. 2011.10.018 PMID: 22209049
3. Nel I, David P, Gerken GH, Schlaak J, Hoffmann A-C (2014) Role of circulating tumor cells and cancer stem cells in hepatocellular carcinoma. Hepatology International 8:321-329. doi: 10.1007/s12072-014-9539-3 PMID: 26202635
4. Alix-Panabieres C, Pantel K (2013) Circulating tumor cells: liquid biopsy of cancer. Clin Chem 59:110-118. doi: 10.1373/clinchem.2012.194258 PMID: 23014601
5. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, et al. (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339:580-584. doi: 10. 1126/science.1228522 PMID: 23372014
6. Hernandez-Yanez M, Heymach JV, Zurita AJ (2012) Circulating biomarkers in advanced renal cell carcinoma: clinical applications. Curr Oncol Rep 14:221-229. doi: 10.1007/s11912-012-0231-2 PMID: 22434312
7. Bluemke K, Bilkenroth U, Meye A, Fuessel S, Lautenschlaeger C, Goebel S, et al. (2009) Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis. Cancer Epidemiol Biomarkers Prev 18:2190-2194. doi: 10.1158/1055-9965. EPI-08-1178 PMID: 19661076
8. Gradilone A, Iacovelli R, Cortesi E, Raimondi C, Gianni W, Nicolazzo C, et al. (2011) Circulating tumor cells and "suspicious objects" evaluated through CellSearch (R) in metastatic renal cell carcinoma. Anticancer Res 31:4219-4221. PMID: 22199284
9. Nel I, Jehn U, Gauler T, Hoffmann AC (2014) Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment. Transl Lung Cancer Res 3:100-106. doi: 10.3978/j.issn. 2218-6751.2014.03.05 PMID: 25806288
10. Nel I, Baba HA, Ertle J, Weber F, Sitek B, Eisenacher M, et al. (2013) Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinoma. Transl Oncol 6:420-428. PMID: 23908685
11. Weller P, Nel I, Hassenkamp P, Gauler T, Schlueter A, Lang S, et al. (2014) Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC). PLoS One 9.
12. Nel I, Baba HA, Weber F, Sitek B, Eisenacher M, Meyer HE, et al. (2014) IGFBP1 in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinoma. Biomarkers in Medicine 8:687-698. doi: 10.2217/bmm.14.23 PMID: 25123037
13. Nel I, Gauler T, Hoffmann AC (2014) Circulating tumor cell composition and outcome in patients with solid tumors. International Journal of Clinical Pharmacology and Therapeutics 52:74-75. doi: 10.5414/CPXCES13EA01 PMID: 24216145
14. Ahn HS, Lee HJ, Hahn S, Kim WH, Lee KU, Sano T, et al. (2010) Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification. Cancer 116:5592-5598. doi: 10.1002/cncr.25550 PMID: 20737569
15. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228-247. doi: 10.1016/j.ejca.2008.10.026 PMID: 19097774
16. Tuveson DA, Willis NA, Jacks T, Griffin JD, Singer S, Fletcher CDM, et al. (2001) STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications. Oncogene 20:5054-5058. PMID: 11526490
17. Goergens A, Ludwig AK, Moellmann M, Krawczyk A, Duerig J, Hanenberg H, et al. (2014) Multipotent Hematopoietic Progenitors Divide Asymmetrically to Create Progenitors of the Lymphomyeloid and Erythromyeloid Lineages. Stem Cell Reports 3:1058-1072. doi: 10.1016/j.stemcr.2014.09.016 PMID: 25448068
18. Leurs C, Jansen M, Pollok KE, Heinkelein M, Schmidt M, Wissler M, et al. (2003) Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells. Hum Gene Ther 14:509-519. PMID: 12718762
19. Mochizuki H, Schwartz JP, Tanaka K, Brady RO, Reiser J (1998) High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J Virol 72:8873-8883. PMID: 9765432
20. Müllers E, Uhlig T, Stirnnagel K, Fiebig U, Zentgraf H, Lindemann D. (2011) Novel functions of prototype foamy virus Gag glycine-arginine-rich boxes in reverse transcription and particle morphogenesis. J Virol 85:1452-1463. doi: 10.1128/JVI.01731-10 PMID: 21106749
21. Hoffmann AC, Wild P, Leicht C, Bertz S, Danenberg KD, Danenberg PV, et al. (2010) MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. Neoplasia 12:628-636. PMID: 20689757
22. Hoffmann AC, Danenberg KD, Taubert H, Danenberg PV, Wuerl P (2009) A three-gene signature for outcome in soft tissue sarcoma. Clin Cancer Res 15:5191-5198. doi: 10.1158/1078-0432. CCR-08-2534 PMID: 19671876
23. Hoffmann AC, Mori R, Vallbohmer D, Brabender J, Klein E, Drebber U, et al. (2008) High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF. Neoplasia 10:674-679. PMID: 18592007
24. Sarkar FH, Li Y, Wang Z, Kong D (2009) Pancreatic cancer stem cells and EMT in drug resistance and metastasis. Minerva Chir 64:489-500. PMID: 19859039
25. Pirozzi G, Tirino V, Camerlingo R, La Rocca A, Martucci N, Scognamiglio R, et al. (2013) Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer. Oncol Rep 29:1763-1768. doi: 10.3892/or.2013.2294 PMID: 23426441
26. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, et al. (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313-323. doi: 10.1016/j.stem.2007.06.002 PMID: 18371365
27. Jiang YS, Jiang T, Huang B, Chen PS, Ouyang J (2013) Epithelial-mesenchymal transition of renal tubules: Divergent processes of repairing in acute or chronic injury? Med Hypotheses 81:73-75. doi: 10.1016/j.mehy.2013.03.020 PMID: 23601763
28. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715. doi: 10.1016/j.cell.2008.03. 027 PMID: 18485877
29. Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD, et al. (2011) Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res 9:997-1007. doi: 10.1158/1541-7786. MCR-10-0490 PMID: 21665936
30. Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M, et al. (2004) N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res 10:4125-4133. PMID: 15217949
31. Thiery JP (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15:740-746. PMID: 14644200
32. Gradilone A, Raimondi C, Nicolazzo C, Petracca A, Gandini O, Vincenzi B, et al. (2011) Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal. J Cell Mol Med 15:1066-1070. doi: 10.1111/j.1582-4934.2011.01285.x PMID: 21352474
33. Raimondi C, Gradilone A, Naso G, Vincenzi B, Petracca A, Nicolazzo C, et al. (2011) Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Res Treat 130:449-455. doi: 10.1007/s10549-011-1373-x PMID: 21298334
34. Chong PP, Selvaratnam L, Abbas AA, Kamarul T (2012) Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells. J Orthop Res 30:634-642. doi: 10.1002/jor.21556 PMID: 21922534
35. Kassis I, Zangi L, Rivkin R, Levdansky L, Samuel S, Marx G, et al. (2006) Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant 37:967-976. PMID: 16670702
36. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM (2003) Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121:368-374. PMID: 12694261
37. Roufosse CA, Direkze NC, Otto WR, Wright NA (2004) Circulating mesenchymal stem cells. Int J Biochem Cell Biol 36:585-597. PMID: 15010325
38. Yang FC, Watanabe S, Tsuji K, Xu MJ, Kaneko A, Ebihara Y, et al. (1998) Human granulocyte colonystimulating factor (G-CSF) stimulates the in vitro and in vivo development but not commitment of primitive multipotential progenitors from transgenic mice expressing the human G-CSF receptor. Blood 92:4632-4640. PMID: 9845529
39. Cesselli D, Beltrami AP, Rigo S, Bergamin N, D'Aurizio F, Verardo R, et al. (2009) Multipotent progenitor cells are present in human peripheral blood. Circ Res 104:1225-1234. doi: 10.1161/CIRCRESAHA.109.195859 PMID: 19390058
40. Klopp AH, Spaeth EL, Dembinski JL, Woodward WA, Munshi A, Meyn RE, et al. (2007) Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res 67:11687-11695. PMID: 18089798
41. Yu M, Stott S, Toner M, Maheswaran S, Haber DA (2011) Circulating tumor cells: approaches to isolation and characterization. J Cell Biol 192:373-382. doi: 10.1083/jcb.201010021 PMID: 21300848
42. Joly E, Hudrisier D (2003) What is trogocytosis and what is its purpose? Nat Immunol 4:815. PMID: 12942076
43. Chen S, Hou JH, Feng XY, Zhang XS, Zhou ZW, Yun JP, et al. (2013) Clinicopathologic Significance of Putative Stem Cell Marker, CD44 and CD133, in Human Gastric Carcinoma. J Surg Oncol 107:799-806. doi: 10.1002/jso.23337 PMID: 23609373
44. Gruenwald V, Beutel G, Schuch-Jantsch S, Reuter C, Ivanyi P, Ganser A, et al. (2010) Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib. BMC Cancer 10:695. doi: 10.1186/1471-2407-10-695 PMID: 21194438
45. Bitting RL, Boominathan R, Rao C, Kemeny G, Foulk B, Garcia-Blanco MA, et al. (2013) Development of a method to isolate circulating tumor cells using mesenchymal-based capture. Methods 64:129-136. doi: 10.1016/j.ymeth.2013.06.034 PMID: 23845299